The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible loan note

28 Jan 2021 07:00

RNS Number : 1312N
Plutus PowerGen PLC
28 January 2021
 

28 January 2021

 

Plutus PowerGen plc

('Plutus' or 'the Company')

Convertible loan note

The Board of Plutus, an AIM Rule 15 cash shell, announces that it has entered into convertible subscription agreements to raise £200,000, before expenses, through the issue of unsecured convertible loan notes (the "Convertible Loans"). The Company is raising the funds to assist the Company in covering the additional costs of any potential future reverse takeover transaction and for general working capital purposes.

 

The Convertible Loans were placed with clients of Pello Capital Limited, the Company's joint broker and placing agent for the purposes of the issue of the Convertible Loans.

 

The key terms of the Convertible Loans are as follows:

 

- 12 month term;

- 8% annual interest rate, payable in cash in arrears on 31 January, 30 April, 31 July and 31 October, with the first instalment due to be paid on 30 April 2021;

- principal and accrued but unpaid interest will be convertible at a 25 per cent. discount to the price of new ordinary shares that are issued pursuant to a placing conducted simultaneous with the re-admission of the ordinary shares of the Company to trading on AIM becoming effective following an acquisition or acquisitions which constitute a reverse takeover under Rule 14 of the AIM Rules ("Re-Admission");

- convertible at the date of Re-Admission; and

- unsecured.

 

The Company expects to receive the funds from the issue of the Convertible Loans by the beginning of February 2021.

 

As announced on 8 January 2021 the Directors are focused on sourcing an appropriate reverse takeover candidate. At present, no assurances can be provided that the effort will be successful to source and/or complete a reverse takeover transaction.

 

The Company was reclassified as an AIM Rule 15 cash shell on 10 December 2020. Following its reclassification as an AIM Rule 15 cash shell, the Company is required to make an acquisition which constitutes a reverse takeover under the AIM Rules by 10 June 2021, failing which the Company's ordinary shares would be suspended from trading on AIM pursuant to AIM Rule 40. The Company's admission to trading on AIM would then be cancelled six months from the date of suspension, should the reason for the suspension not have been rectified.

 

The Company's Directors will provide shareholders with further updates as appropriate.

 

Plutus PowerGen PLC

Charles Tatnall, Executive Chairman

James Longley, Interim CEO and Finance Director

 

 

Tel: +44 (0) 20 8720 6562

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Nick Athanas

Nick Naylor

George Payne

 

 

Tel: +44 (0)20 3328 5656

Turner Pope Investments (TPI) Limited (Joint Broker)

Andy Thacker

 

Pello Capital Limited (Joint Broker)

Mark Treharne

 

Tel: +44 (0) 20 3657 0050

 

 

Tel: +44 (0) 20 3700 2492

 

St Brides Partners Limited (Financial PR)

Cosima Akerman

 

 

Tel: +44 (0)20 7236 1177

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRMBTMTBTTIB
Date   Source Headline
15th Oct 20121:00 pmRNSDisposal
10th Oct 20127:30 amRNSSuspension - IPSO Ventures Plc
10th Oct 20127:30 amRNSStatement re. Suspension
29th Aug 20127:00 amRNSHolding(s) in Company
10th Aug 20127:00 amRNSDirector/PDMR Shareholding
3rd Aug 201212:40 pmRNSReplacement - Director Shareholding
3rd Aug 20127:00 amRNSDirector/PDMR Shareholding
15th Jun 20127:00 amRNSHolding(s) in Company
18th Apr 20127:00 amRNSDirector/PDMR Shareholding
29th Feb 20127:00 amRNSTotal Voting Rights
8th Feb 20127:00 amRNSIssue of equity, directors' shareholdings and TVR
23rd Jan 20127:01 amRNSHalf Yearly Report
17th Jan 20124:30 pmRNSHolding(s) in Company
30th Nov 20117:00 amRNSTotal Voting Rights
18th Nov 20117:00 amRNSIssue of Equity
14th Nov 20112:00 pmRNSDirector/PDMR Shareholding
1st Nov 20114:20 pmRNSChange of Registered Office
24th Oct 20117:00 amRNSAIM Rule 17 Disclosures
12th Oct 20117:00 amRNSIPSol Energy successful fund raising
3rd Oct 20115:15 pmRNSHolding(s) in Company
30th Sep 201110:00 amRNSTotal Voting Rights
30th Sep 20119:00 amRNSHolding(s) in Company
22nd Sep 20111:50 pmRNSHolding(s) in Company
15th Sep 20112:15 pmRNSEU grants approval for Buccolam
9th Sep 20111:00 pmRNSResult of AGM
25th Aug 20111:35 pmRNSIssue of Equity and Director Dealings
19th Aug 20117:00 amRNSFinal Results
8th Aug 20117:00 amRNSDirectorate Changes
12th Jul 20117:00 amRNSTermination of Loughborough University agreement
7th Jul 201110:35 amRNSCompletion of placing to raise £195,000
1st Jul 20117:00 amRNSTherakind Product Update
29th Jun 20111:05 pmRNSResult of General Meeting
27th Jun 20117:00 amRNSFurther re General Meeting
24th Jun 20117:00 amRNSHolding(s) in Company
22nd Jun 20114:58 pmRNSHolding(s) in Company
22nd Jun 20117:00 amRNSShareholding in Biocroi
13th Jun 20113:50 pmRNSProposed Placing to raise £195,000/Notice of GM
25th May 20115:10 pmRNSHolding(s) in Company
24th May 20117:00 amRNSCambridge Meditech agreement with Lantor (UK)
25th Mar 20117:00 amRNSTrading update
11th Feb 20117:00 amRNSHolding(s) in Company
8th Feb 20111:30 pmRNSHolding(s) in Company
26th Jan 20113:30 pmRNSHolding(s) in Company
5th Jan 20117:00 amRNSHalf Yearly Report
8th Oct 20103:15 pmRNSDirector/PDMR Shareholding
8th Oct 20108:00 amRNSDirectorate Change
13th Sep 20107:00 amRNSAllotment of Adviser Shares
10th Sep 201012:30 pmRNSResult of AGM
27th Aug 201012:20 pmRNSResult of General Meeting
20th Aug 20107:00 amRNSPosting of Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.